Annual report pursuant to Section 13 and 15(d)

Research Agreement (Details)

v3.6.0.2
Research Agreement (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2016
Jun. 30, 2015
Dec. 31, 2016
Dec. 31, 2015
Research Agreement        
Revenue $ 317 $ 317 $ 317 $ 317
Multinational Pharmaceutical Company | Research Agreement        
Research Agreement        
Maximum funding available     3,000  
Revenue     $ 300 $ 300